Биология ва тиббиёт муаммолари 2026, №1 (167)

Тема статьи

ҚАНДЛИ ДИАБЕТНИНГ ПРОФИЛАКТИКАСИ, ДИАГНОСТИКАСИ ВА ДАВОЛАШДА ГЕНОМНИНГ АҲАМИЯТИ (354-358)

Авторы

Абдуллаев Бахтиёр Саидович, Бахтиёров Абдуазиз Уткурович

Учреждение

Самарқанд Давлат тиббиёт университети, Ўзбекистон Республикаси, Самарқанд ш.

Аннотация

Геном бўйича олиб борилган тадқиқотларнинг 25% эндокрин касалликларга бағишланган. Гарчи бу кашфиётлар ҳали клиник ёрдамга жиддий таъсир кўрсатмаган бўлса-да, генетика эртанги куннинг дори воситаларини кашф қилишда катта таъсир кўрсатади. Бу эса экспериментал ва биоинформатика ютуқлари ёрдамида генларни кашф қилишдан дори ишлаб чиқишгача бўлган вақтни қисқартириш имконини беради.

Ключевые слова

Ген мутацияси, KCNJ11 ва АВСС8, Липоатрофик қандли диабет, GWAS, PPARG, MODY.

Литературы

1. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y: A novel subtype of type 1 diabetes mellitus char-acterized by a rapid onset and an absence of diabe-tes-related antibodies. Osaka IDDM Study Group. N Engl J Med 342:301, 2000. 2. Wellcome Trust Case Control Consortium. Ge-nome-wide association study of 14,000 cases of sev-en common diseases and 3,000 shared controls. Na-ture 447:661, 2007. 3. Todd JA, Walker NM, Cooper JD et al.: Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 39:857, 2007. 4. Jones EY, Fugger L, Strominger JL, Siebold С: MHC class II proteins and disease: a structural per-spective. Nat Rev Immunol 6:271, 2006. 5. Park Y: Functional evaluation of the type 1 diabe-tes (T1D) susceptibility genes. Diabetes Res Clin Pract 77 Suppl 1: S110, 2007. 6. Chistiakov et al.: The crucial role of IL-2/IL-2RA-mediated immune regulation in the pathogenesis of type 1 diabetes, evidence coming from genetic and animal model studies. Immunol Lett 118:1, 2008. 7. Frayling TM: Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet 8:657, 2007. 8. Rizaev J. A. et al. Study of the tendency to treat-ment of patients with chronic diseases of the cardio-vascular and respiratory system //Symposium on Life and Environmental Sciences. – 2026. – Т. 2. – №. 2. – С. 6-11. 9. Rizaev J. A. Individual factors affecting the sur-vival of patients undergoing hemodialysis //Global Conference on Medical and Health Sciences. – 2026. – Т. 1. – №. 1. – С. 48-51. 10. Gloyn AL et al.: Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 350:1838, 2004. 11. Murphy R et al.: Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mi-tochondrial point mutation. Diabet Med 2008. 12. Stoy J et al.: Insulin gene mutations as a cause of permanent neonatal diabetes. Proc Nat Acad Sci USA 104:15040, 2007. 13. Liu N, Huang R, Baldacchino T, Sud A, Sud K, Khadra M, et al. Telehealth for noncritical patients with chronic diseases during the COVID-19 pan-demic. J Med Internet Res 2020 Aug 07;22(8): e1949 14. Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: prevalence, pathophysiology, progno-sis and practical considerations. Diabetes Metab Syndr 2020;14(4):303-310 15. Al-Shamsi HO, Alhazzani W, Alhuraiji A, Coomes EA, Chemaly RF, Almuhanna M, et al. A practical approach to the management of cancer pa-tients during the novel coronavirus disease 2019 (COVID-19) pandemic: an international collabora-tive group. Oncologist 2020 Jun;25(6): e936-e945. 16. Nouri S, Khoong EC, Lyles CR, Karliner L. Ad-dressing equity in telemedicine for chronic disease management during the Covid-19 pandemic. NEJM Catalyst 2020 May 04;1(3):1-13